Former Pharmaceutical Firm Employee Violates Confidentiality Agreement

ByVictoria Negron

|

Updated onJanuary 6, 2022

Former Pharmaceutical Firm Employee Violates Confidentiality Agreement

This case involves a breach of an employee confidentiality agreement after a senior employee of a biopharmaceutical firm left the company in order to join a competitor. The former employee had knowledge of a particularly important clinical success with an oncology medication of high commercial value. It was alleged that the employee brought trade secrets to her new employer which significantly influenced company strategy through the development of a similar drug. An expert in chemistry was sought to can compare the relevant drugs from both the plaintiff and the defendant and opine on whether or not the defendant’s drug incorporated elements of the plaintiff’s drug in its development process.

Question(s) For Expert Witness

1. Please describe your background in chemistry as it relates to new drug development.

2. Are you capable of analyzing iterations of two similar molecules and opining on whether or not one incorporated elements from the other?

Expert Witness Response E-111343

inline imageI have a Ph.D. in chemistry, and I have studied oncology medications for more than 15 years. I am familiar with their molecular properties, as well as its interactions with small molecules, such as inhibitors. I have published more than 90 peer-reviewed articles and I am a frequent reviewer for funding agencies and peer-reviewed journals. I have presented a series of public lectures about my research work in national and international institutes and conferences. In addition, I have received millions of dollars grants from National Institute of Health to support my research work on oncology medication research. I have a pending grant and a pending patent on the design/development of inhibitors and my most recent work on a new generation of inhibitors. I have an extensive background in chemistry, bioinorganic chemistry, and biophysical chemistry (on which I have taught a course for several years). Other than my own research work, I am familiar with inhibitors reported in the literature.

About the author

Victoria Negron

Victoria Negron

Victoria Negron has extensive experience in journalism and thought leadership in the legal space, with a background crafting content, whitepapers, webinars, and current event articles pertaining to the role of expert witnesses in complex litigation matters. She is a skilled professional specializing in B2B product marketing and content marketing. Currently, she serves as an Enterprise Product Marketing Manager at Postman, and previously held the position of Technical Product Marketing Manager at Palantir Technologies, where she developed her skills in launch strategies, go-to-market strategy, and competitive analysis.

Her expertise in content marketing was further refined during her tenure at the Expert Institute, where she progressed from a Marketing Writer to Senior Content Marketing Manager, and eventually to Associate Director of Content & Product Marketing. In these roles, she honed her abilities in digital marketing, SEO, content strategy, and thought leadership.

Educationally, Victoria holds a Master of Business Administration from the University of Florida - Warrington College of Business and a Bachelor of Arts in Literature, Art, and Hispanic Studies from Hamilton College. Her diverse educational background and professional experience have equipped her with a robust skill set in product marketing, content development, and strategic marketing initiatives.

Find an expert witness near you

What State is your case in?

What party are you representing?